Patents by Inventor An De Creus

An De Creus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAi
    Publication number: 20220305107
    Abstract: Therapeutic combinations of hepatitis B virus (HBV) vaccines and an RNAi agent for inhibiting the expression of an HBV gene are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals having chronic HBV infection, using the disclosed therapeutic combinations are also described.
    Type: Application
    Filed: June 18, 2020
    Publication date: September 29, 2022
    Inventors: Helen HORTON, An Martine M. DE CREUS, Jan Martin BERKE
  • COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAI
    Publication number: 20220305117
    Abstract: Therapeutic combinations of hepatitis B virus (HBV) vaccines and an RNAi agent for inhibiting the expression of an HBV gene are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals having chronic HBV infection, using the disclosed therapeutic combinations are also described.
    Type: Application
    Filed: June 18, 2020
    Publication date: September 29, 2022
    Inventors: Helen HORTON, An DE CREUS, Jan BERKE
  • COBMINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY
    Publication number: 20220296703
    Abstract: Therapeutic combinations of hepatitis B virus (HBV) vaccines and an anti-PD-1 or anti-PD-L1 antibody or antigen-binding fragment thereof are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals having chronic HBV infection, using the disclosed therapeutic combinations are also described.
    Type: Application
    Filed: June 18, 2020
    Publication date: September 22, 2022
    Inventors: Helen HORTON, An Martine M. DE CREUS, Ellen Rosalie A. VAN GULCK
  • TOLL-LIKE RECEPTOR AGONISTS FOR USE IN THE TREATMENT OF HEPATITIS B
    Publication number: 20220249488
    Abstract: Provided herein are formulations and methods of using a TLR-7 agonist for the treatment of hepatitis B virus infection.
    Type: Application
    Filed: March 13, 2020
    Publication date: August 11, 2022
    Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Peter Jozef M VAN REMOORTERE, Sean Mark DALZIEL, Ilham SMYEJ, Joris Jozef VANDENBOSSCHE, An Martine M DE CREUS, Mina PASTAGIA, Florence Marie HERSCHKE
  • COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND ANTI-PD-1 ANTIBODY
    Publication number: 20220233685
    Abstract: Therapeutic combinations of hepatitis B virus (HBV) vaccines and an anti-PD-1 antibody or antigen-binding fragment thereof are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals having chronic HBV infection, using the disclosed therapeutic combinations are also described.
    Type: Application
    Filed: June 18, 2020
    Publication date: July 28, 2022
    Inventors: Helen HORTON, An Martine M. DE CREUS, Ellen Rosalie A. VAN GULCK
  • DELIVERY OF BINDING MOLECULES TO INDUCE IMMUNOMODULATION
    Publication number: 20100303777
    Abstract: Delivery of binding molecules, such as antibodies, antibody fragments, single antibody variable domains, soluble receptors, ligands and dominant negative variants, to induce an immunomodulation in a patient is disclosed. More specifically, a medicament which includes micro-organisms which produce the binding molecules is described for the treatment of immune mediated diseases.
    Type: Application
    Filed: December 12, 2007
    Publication date: December 2, 2010
    Applicant: ActoGeniX N.V.
    Inventors: An De Creus, Pieter Rottiers